Equine

Equine

Horses
The trademarks indicated by CAPITAL LETTERS in this publication are the property of, licensed to, promoted or distributed by Merck & Co., Inc., its subsidiaries or related companies. As used in this publication, the terms “Merck” and the “company” refer collectively to Merck & Co., Inc., the publicly held parent company, and its domestic and international subsidiaries, which are engaged in the discovery, development, manufacturing and marketing of pharmaceutical, animal health and consumer products worldwide.

Equine

Equilis® Prequenza

Equilis® Prequenza provides active immunization of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunization against tetanus to prevent mortality (Equilis Prequenza Te). Equilis Prequenza provides one year duration of immunity after revaccination. Equilis Prequenza contains ISCOM-Matrix as adjuvant and is available in ready to use syringes and vials


Dolorex®

Dolorex® (butorphanol tartrate), authorized for use in horses as well as dogs, is our newest addition to an ever increasing portfolio. This analgesic is based on butorphanol tartrate and is authorized for use in horses and dogs for pain relief (specifically for the management of colic of gastrointestinal tract origin in horses, and moderate visceral pain in dogs) and sedation in combination with certain α2-adrenoceptor agonists.


DateDescription
18 November 2011Global Animal Management Launches eyeD Equine Identification SystemBOXMEER (The Netherlands), November 18, 2011 – Global Animal Management, a wholly-owned subsidiary of Merck Animal Health (known as MSD Animal Health outside the USA and Canada), introduced this week ...
15 September 2011Candidate Vaccine Against Deadly Pneumonia in FoalsBOXMEER (The Netherlands), September 15, 2011 - Rhodococcus equi bacteria can cause “rattles”, a potentially lethal disease in foals which is characterized by pneumonia and gastro-intestinal infection. ...
27 January 2011Candidate vaccine against Rhodococcus equi infections in foals to be investigated in field trial in GermanyBoxmeer (the Netherlands), January 27, 2011 – Intervet/Schering-Plough Animal Health announces today that it is entering the final stage of development of a vaccine against Rhodococcus equi, a bacteria ...
30 September 2010Intervet/Schering-Plough Animal Health sponsors Equine Business Management Strategies programBOXMEER (The Netherlands), September 30, 2010 – Intervet/Schering-Plough Animal Health announced today that it has entered into an agreement to sponsor the Equine Business Management Strategies (EBMS) ...
1 June 2010Equine strangles vaccine returns to the market in EuropeBOXMEER (the Netherlands), June 1, 2010 – Intervet/Schering-Plough Animal Health, the European market leader in equine vaccines, today announces that it is re-introducing EQUILIS® StrepE, the only strangles ...
29 September 2009Intervet/Schering-Plough Animal Health completes first wave of launches of VECTIN, an antiparasitic drug for horses formulated as a tasty cookieBOXMEER (the Netherlands), September 29, 2009 — Intervet/Schering-Plough Animal Health today announces that it has completed the first wave of market introductions of VECTIN® (ivermectin chewable tablets), ...
20 August 2008Intervet/Schering-Plough Animal Health shows innovative portfolio at WSAVA congress, Dublin - Hubert Trentesaux appointed as head of Global Companion AnimalBOXMEER (the Netherlands), August 20, 2008 – At the 33rd annual World Small Animal Veterinary Association Congress (WSAVA) in Dublin, Ireland, August 20-24, Intervet/Schering-Plough Animal Health, presents ...
28 July 2008Intervet/Schering-Plough Animal Health Scholarship on Equine and Critical Care - First European Equine Emergency and Critical Care Scholarship launched in IrelandBOXMEER (the Netherlands), July 28, 2008 - A new scholarship on Equine Emergency and Critical Care has been started at a specialist equine hospital in County Kildare, at the heart of Ireland’s horse-racing ...
28 September 2007Intervet Inc. sponsored webinar on West Nile virusSince West Nile virus emerged in the United States in 1999, more than 24,671 horses have been infected. Fall is when horse owners and veterinarians most often see this deadly virus emerge. In order to ...
2 August 2007New updated edition of the Compendium of Animal Reproduction availableNew edition of the Compendium of Animal Reproduction was published by Intervet International. This 9th revised edition was updated with the latest scientific information regarding the physiological regulation ...
22 January 2007Intervet launches Prestige IV Foalshot with Havlogen and Intervet Foal Care Program in USIntervet launched Prestige IV Foalshot with Havlogen, a vaccine to protect foals against diseases caused by Eastern and Western encephalomyelitis and tetanus and to control respiratory disease caused ...
1 November 2006Intervet launches innovative equine flu vaccinesEquine influenza continues to be the most common viral respiratory disease found in horses and is endemic in many populations throughout the world. And, with several recent outbreaks, prevention has ...
14 September 2006Intervet’s equine West Nile vaccine approved by USDAAn equine vaccine developed by Akzo Nobel’s animal health business Intervet, which is indicated for use in horses at risk from West Nile virus has been approved by the United States Department of Agriculture ...
30 January 2006A better life for 1000 horsesMost of Romania's estimated one million horses are working animals. They fulfill essential roles in local communities - working on farm land, in the forestry sector or transporting goods - but few receive ...
15 December 2005Reducing animal testingClostridial bacteria produce toxins that cause a range of diseases in animals. Vaccines against these diseases are often developed from the toxins themselves. The production of clostridial vaccines involves ...